CDK4 and cancer: These are specific for CDK4 and CDK6 [132] and can bind in presence or absence of cyclin D. Changes in the expression level or mutations in cyclin D1, CDK4, CDKI and pRB are strongly implicated in cancer [123,133,134,135,136].